Viewray Systems, Inc.

ViewRay Systems, Inc. is a medical device manufacturer specializing in MRI-guided radiation therapy (MR-gRT) systems for precision cancer treatment. The company's flagship product, MRIdian A3i, integrates diagnostic-quality MRI imaging with radiation delivery and proprietary software to enable real-time soft-tissue visualization, automated beam control, and adaptive dosing. This technology allows radiation oncology centers to reduce treatment volumes, minimize side effects, and improve patient outcomes across multiple cancer types including pancreatic, prostate, lung, liver, breast, and oligometastatic cancers. MRIdian A3i is compatible with existing radiation therapy vaults, facilitating institutional adoption. ViewRay Systems serves university hospitals, community hospitals, private practices, and specialized cancer centers worldwide, supporting program expansion in advanced precision oncology with peer-reviewed clinical evidence demonstrating reduced treatment toxicity and extended survival.